Notice - Prescription Drug List (PDL): Triamcinolone acetonide

The purpose of this Notice of Amendment is to announce the revised listing for Adrenocortical hormones to allow the nonprescription use of triamcinolone acetonide for the conditions listed below. Only the Human part of the PDL has been revised.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-09-29

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data